Jazz Pharmaceuticals plc buy JPMorgan Chase & Co.
Start price
19.08.24
/
50%
€102.30
Target price
19.08.25
€182.69
Performance (%)
-0.24%
Price
21.08.24
€102.60
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ for Jazz Pharmaceuticals plc is nearly unchanged. This prediction currently runs until 19.08.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Jazz Pharmaceuticals plc | -0.24% |
iShares Core DAX® | 3.126% |
iShares Nasdaq 100 | 3.003% |
iShares Nikkei 225® | 4.991% |
iShares S&P 500 | 1.852% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target raised by analysts at JPMorgan Chase & Co. from $190.00 to $202.00. They now have an "overweight" rating on the stock.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€112.05
25.03.24
25.03.24
€175.31
25.03.25
25.03.25
-8.43%
21.08.24
21.08.24
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€109.35
29.02.24
29.02.24
€157.28
28.02.25
28.02.25
-6.17%
21.08.24
21.08.24